Biocon’s Executive Chairperson Kiran Mazumdar-Shaw has mapped a five-year succession plan, naming her niece Claire Mazumdar as successor. The company expects a strong FY27 launch calendar, especially in the second half, driven by its “diabesity” franchise. It also reports significant debt reduction and will channel more operational cash flow toward further deleveraging as it targets a semaglutide push from FY28.
Noel Tata, approaching 70 in November, is set to step down from boards of Tata group companies, triggering a major leadership reshuffle. The group has begun discussions to appoint replacements to keep key businesses running smoothly, following its governance approach that non-executive executives retire at 70. Changes are expected soon.
Your news, in seconds
Get the Beige app — every story in 60 words, updated hourly. Free on iOS & Android.
Kiran Mazumdar-Shaw has named her niece Claire Mazumdar as her successor at Biocon, launching a gradual leadership transition. The founder, who built the biotech company from a garage into a global player, will remain involved while Claire—positioned as a more science-driven leader—takes on increasing responsibility during the handover period.
Nitish Kumar has stepped down from the Bihar Legislative Council and is set to enter the Rajya Sabha in early April. The move follows an unofficial pledge to step aside at 75, signaling a shift from state administration to the national arena. Political observers view it as a major gesture that could influence how succession and leadership transition unfold in Bihar and beyond.
Swipe through stories, personalise your feed, and save articles for later — all on the app.
